Using Triflow to help adults with long COVID in rehabilitation
The Use of Incentive Spirometry (Triflow) in Patients With Long Covid
This study is testing if using a special breathing device called Triflow can help adults with long COVID recover better during their rehabilitation exercises.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European University Cyprus Academic / other |
| Locations | 1 site (Larnaca) |
| Trial ID | NCT05813873 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of Triflow, an incentive spirometry device, in aiding the rehabilitation of adults hospitalized with long COVID syndrome. Participants will be randomly assigned to either an intervention group that incorporates Triflow into their exercise regimen or a control group that follows the same exercise program without Triflow. Both groups will engage in a variety of exercises under the supervision of physiotherapists for six days a week until discharge. The study aims to assess the impact of Triflow on recovery outcomes for these patients.
Who should consider this trial
Good fit: Ideal candidates are adults who have been diagnosed with long COVID within the last six months and are currently hospitalized for rehabilitation.
Not a fit: Patients with unstable cardiac conditions or significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and improve respiratory function in patients suffering from long COVID.
How similar studies have performed: While there are few published studies on Triflow as a primary intervention, this approach is relatively novel in the context of long COVID rehabilitation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults who were infected with COVID-19 in the last 6 months and were diagnosed with long-covid syndrome * Patients must be willing to give written consent for participation in the study * Negative rapid test for COVID-19 Exclusion Criteria: * History of diseases that do not allow exercise (e.g. unstable cardiac disease) * Age \< 18 years of age * Significant cognitive and psychiatric impairments (inability to follow simple commands or give consent) * Lack of will to do the exercises or refuse to give consent
Where this trial is running
Larnaca
- Eden Resort Wellness Rehabilitation Center — Larnaca, Cyprus (Recruiting)
Study contacts
- Principal investigator: Marina Kloni — European University Cyprus
- Study coordinator: Marina E Kloni
- Email: marina.eleni@gmail.com
- Phone: 0035799007245
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.